The hazards of endpoints.
Berry
Donald A
DA
D014408:Biomarkers, Tumor / Q000378:metabolism*; D002986:Clinical Trials as Topic / Q000592:standards* / Q000639:trends; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy / Q000379:methods* / Q000592:standards / Q000639:trends; D053208:Kaplan-Meier Estimate; D015233:Models, Statistical; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*; D017063:Outcome Assessment, Health Care; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D013997:Time Factors; D016896:Treatment Outcome
D014408:Biomarkers, Tumor